WallStreetZenWallStreetZen

NASDAQ: ALLR
Allarity Therapeutics Inc Earnings & Revenue

ALLR earnings and revenue history

Current Revenue
$0.0
Current Earnings
-$20.9M
Current Profit Margin
0%

ALLR Return on Equity

Current Company
N/A
Current Industry
16.7%
Current Market
28.2%

Be the first to know when ALLR announces earnings.

ALLR Return on Assets

Current Company
-163.8%
Current Industry
3.1%
ALLR is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

ALLR Return on Capital Employed

Current Company
195.48%
Current Industry
-43.6%

ALLR vs Biotech Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
ALLR$0.00-$11.78M-$20.94MN/AN/A
OGEN$20.63k-$20.21M-$20.26M-55.04%N/A
COEP$0.00-$15.03M-$16.31M-100.00%N/A
AVTX$1.45M-$140.24M-$142.88M-22.31%N/A
ATHE$0.00N/A-$8.03MN/AN/A

Allarity Therapeutics Earnings & Revenue FAQ

What were ALLR's earnings last quarter?

Allarity Therapeutics (NASDAQ: ALLR) reported Q1 2024 earnings per share (EPS) of -$22.14, up 99.65% year over year. Total Allarity Therapeutics earnings for the quarter were -$3.88 million. In the same quarter last year, Allarity Therapeutics's earnings per share (EPS) was -$6,356.06.

If you're new to stock investing, here's how to buy Allarity Therapeutics stock.

What was ALLR's earnings growth in the past year?

As of Q2 2024, Allarity Therapeutics's earnings has grown year over year. Allarity Therapeutics's earnings in the past year totalled -$20.94 million.

What was ALLR's revenue last quarter?

Allarity Therapeutics (NASDAQ: ALLR) reported Q1 2024 revenue of $0.00 up N/A year over year. In the same quarter last year, Allarity Therapeutics's revenue was $0.00.

What was ALLR's revenue growth in the past year?

As of Q2 2024, Allarity Therapeutics's revenue has grown null year over year. Allarity Therapeutics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.